Many factors including genetic, environmental, and acquired are involved in breast cancer development across various societies. Among all of these factors in families with a history of breast cancer throughout several generations, genetics, like predisposing genes to develop this disease, should be considered more. Early detection of mutation carriers in these genes, in turn, can play an important role in its prevention. Because this disease has a high prevalence in half of the global population, female screening of reported mutations in predisposing genes, which have been seen in breast cancer patients, seems necessary. In this review, a number of mutations in two predisposing genes (BRCA1 and BRCA2) that occurred in patients with a family history was investigated. We studied published articles about mutations in genes predisposed to breast cancer between 2000 and 2015. We then summarized and classified reported mutations in these two genes to recommend some exons which have a high potential to mutate. According to previous studies, exons have been reported as most mutated exons presented in this article. Considering the large size and high cost of screening all exons in these two genes in patients with a family history, especially in developing countries, the results of this review article can be beneficial and helpful in the selection of exon to screen for patients with this disease.
BRCA1 BRCA2 mutations breast cancer, hereditary breast cancer genetic risk, tumor suppressor gene breast cancer, BRCA mutation carrier detection, genetic predisposition breast cancer, BRCA germline mutations screening, familial breast cancer genetics, DNA repair gene breast cancer, breast cancer susceptibility genes, early detection BRCA mutation carriers
PMID 27493913 27493913 DOI 10.18869/mjiri.30.369 10.18869/mjiri.30.369
Cite this article
Mehrgou, A., & Akouchekian, M. (2016). The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. *Medical journal of the Islamic Republic of Iran*, *30*, 369. https://doi.org/10.18869/mjiri.30.369
Mehrgou A, Akouchekian M. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Med J Islam Repub Iran. 2016;30:369. doi:10.18869/mjiri.30.369
Mehrgou, Amir, and Mansoureh Akouchekian. "The importance of BRCA1 and BRCA2 genes mutations in breast cancer development." *Medical journal of the Islamic Republic of Iran*, vol. 30, 2016, pp. 369.
Curcumin, a bioactive polyphenol derived from turmeric (Curcuma longa), has garnered substantial attention for its potent anti-inflammatory, antioxidant, and antineoplastic properties. This review exp...
Wallace ME et al., 2026American journal of public health
Objectives. To quantify the impact of state abortion bans on trends in fertility and preterm birth following the June 2022 US Supreme Court decision in Dobbs v Jackson Women's Health Organization. Met...
Jain N et al., 2026Women's health (London, England)
BACKGROUND: Healthcare professionals' and students' willingness to provide abortion influences access to care and workforce readiness.
OBJECTIVE: We conducted a literature synthesis to identify patte...
GBD 2021 AEMT Collaborators, 2026The Korean journal of internal medicine
BACKGROUND/AIMS: This study aims to evaluate the global burden of adverse effects of medical treatment (AEMT) using data from the Global Burden of Disease Study (GBD) 2021.
METHODS: Data were extract...